TABLE 1. Demographic Data of Patients Enrolled in Groups I and II.
| Characteristics | Group I | Group II |
|---|---|---|
| Male/Female | 27/45 | 160/126 |
| Age, years | ||
| Mean ± standard deviation (range) | 33 ± 9.4 (18 – 55) | 51 ± 12.5 (19 – 79) |
| Median | 31 | 52 |
| BMI, kg/m2 | ||
| Mean ± standard deviation (range) | 23.3 ± 3.2 (17.3 – 30.4) | 25.9 ± 4.0 (16.8 – 41.2) |
| Median | 22.9 | 25.7 |
| AST, U/L | ||
| Mean ± standard deviation (range) | 24.3 ± 10.1 (15 – 66) | 73.5 ± 80.8 (3.5 – 901) |
| Median | 21 | 51 |
| ALT, U/L | ||
| Mean ± standard deviation (range) | 22.3 ± 19.5 (5 – 114) | 110.6 ± 155.9 (8 – 2034) |
| Median | 15 | 77 |
| Hepatic steatosis grade, no. of patients | ||
| Normal | – | 97 |
| Mild | – | 77 |
| Moderate | – | 43 |
| Severe | – | 69 |
Unless otherwise noted, data are expressed as numbers of patients. BMI: body mass index, AST: aspartate aminotransferase, ALT: alanine aminotransferase. Normal AST levels for female and male patients are less than 35 and 50 U/L, respectively. Normal ALT levels for female and male patients are less than 19 and 30 U/L, respectively.